The largest insider buy on today’s list is a Form 4 filing by Michael Gladstone, independent director at Day One Biopharmaceuticals $DAWN.

Gladstone disclosed the purchase of approximately $11.5 million worth of shares in the mid-cap biotech company.

Do you remember 2017?

The memes going around those days were about how many days it had been since the S&P500 fell by over 1%.

Volatility was non-existent.

And this was hilarious to me, of course, living in California at the time and people freaking out about the Trump victory at the end of 2016.

With sentiment down in the dumps entering 2017, that sparked one of the greatest return / least volatile years on record.

In fact, 2017 had only 8 trading days on which the S&P500 was +/- 1%.

Every month so far this year has had at least that many:

From the desk of Steve Strazza @Sstrazza

Welcome to the 2 to 100 Club.

As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach. It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

This is the video recording of our June 22, 2022, Inside Scoop Weekly Strategy Session.

SkyKnight Capital Fund disclosed the purchase of approximately $1.6 million worth of shares in the home medical equipment company AdaptHealth Corp $AHCO, as it continues to build a position in the stock.

The fund now owns 8,906,070 shares, which represents a roughly 6.15% ownership stake in the medical devices company.

The market correction has extended over the past few weeks and the negative sentiment build-up is definitely not something that will fade away quickly. As more and more sectors move below their support zones, buy ideas are hard to come by. Today we're sharing a short idea from the financial services sector.

From the desk of Steve Strazza @Sstrazza

Welcome to our latest Minor Leaguers report.

We’ve had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.

The largest insider transaction on today’s list comes in a Form 4 filing from Allied Physicians of California.

The firm reported a purchase of roughly $9.2 million in Apollo Medical Holdings $AMEH. It now owns about 11 million shares for a total ownership interest of 19%.

This is the video recording of the June 2022 Mid-month Conference Call.

We discussed:

• The S&P500 and Dow Jones Composite stuck below overhead supply
• Major US Indexes are below their AVWAPs from the COVID lows
• 30 consecutive weeks of more stocks making new lows than new highs
• Seasonality could become a tailwind in July
• Sentiment is as bad for stocks as I've ever seen
• Relative strength out of Chinese Internet and other "culprits"
• Bitcoin near important support
• The US Dollar controls all of this. All eyes on DXY
• Breadth Deterioration in Commodities
• Long opportunities in Financials
• Defensive Sectors are vulnerable
• Gold is still below overhead supply
• Copper/Gold ratio breaking down pointing to lower rates
• Japanese Yen hits new multi-decade lows
• Buy the dip in bonds? I think so

From the desk of Steve Strazza @sstrazza

This is one of our favorite bottom-up scans: Follow the Flow. In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

How's the Bear Market treating you?

We're going on over 16 months of this so far, and counting....

Remember, stocks peaked in February of 2021, meaning that was the best things were for stocks during this cycle. And it's been a slow deterioration ever since.

The first stocks to peak are what we refer to as the "Culprits". Every bear market has that group that you can point to as the leaders to the downside.

We came into 2022 with a close eye on those Culprits (see here) and we've continued to monitor their declines.

If you haven't been following along, those groups include Chinese Internet, Biotechnology, the IPO stocks, and of course Cathie Wood's ARKK Funds, who have become the poster child for this latest bubble.

But a funny thing happened 6 weeks ago - they all stopped going down.

And the leader to the upside has been Chinese Internet (yes you read that right, I had to run the numbers multiple times to believe it myself).